Gw&K Investment Management, LLC Neurocrine Biosciences Inc Transaction History

Gw&K Investment Management, LLC

  • $11.3 Billion
  • Q3 2025

A detailed history of Gw&K Investment Management, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Gw&K Investment Management, LLC holds 594,385 shares of NBIX stock, worth $86.1 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares
594,385
Previous 612,365 2.94%
Holding current value
$86.1 Million
Previous $77 Million 8.41%
% of portfolio
0.74%
Previous 0.69%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025
SELL
$123.98 - $146.67 $2.23 Million - $2.64 Million
-17,980 Reduced 2.94%
594,385 $83.4 Million
Q2 2025

Aug 11, 2025
BUY
$87.54 - $128.18 $8.84 Million - $12.9 Million
101,009 Added 19.75%
612,365 $77 Million
Q1 2025

May 05, 2025
SELL
$107.22 - $153.29 $292,281 - $417,868
-2,726 Reduced 0.53%
511,356 $56.6 Million
Q4 2024

Feb 05, 2025
BUY
$111.62 - $139.44 $445,698 - $556,783
3,993 Added 0.78%
514,082 $70.2 Million
Q3 2024

Nov 07, 2024
SELL
$114.58 - $153.15 $4.12 Million - $5.51 Million
-35,979 Reduced 6.59%
510,089 $58.8 Million
Q2 2024

Aug 12, 2024
BUY
$130.86 - $143.19 $2.38 Million - $2.61 Million
18,194 Added 3.45%
546,068 $75.2 Million
Q1 2024

May 08, 2024
SELL
$130.4 - $143.74 $1.05 Million - $1.16 Million
-8,088 Reduced 1.51%
527,874 $72.8 Million
Q4 2023

Feb 09, 2024
SELL
$106.07 - $132.76 $2 Million - $2.5 Million
-18,829 Reduced 3.39%
535,962 $70.6 Million
Q3 2023

Nov 09, 2023
SELL
$94.02 - $117.1 $1.8 Million - $2.24 Million
-19,164 Reduced 3.34%
554,791 $62.4 Million
Q2 2023

Aug 09, 2023
SELL
$89.53 - $104.87 $612,564 - $717,520
-6,842 Reduced 1.18%
573,955 $54.1 Million
Q1 2023

May 09, 2023
BUY
$94.11 - $123.02 $588,658 - $769,490
6,255 Added 1.09%
580,797 $58.8 Million
Q4 2022

Feb 10, 2023
SELL
$106.72 - $127.06 $2.22 Million - $2.64 Million
-20,786 Reduced 3.49%
574,542 $68.6 Million
Q3 2022

Nov 09, 2022
SELL
$92.03 - $107.81 $1.99 Million - $2.33 Million
-21,581 Reduced 3.5%
595,328 $63.2 Million
Q2 2022

Aug 09, 2022
SELL
$75.79 - $100.07 $4.74 Million - $6.26 Million
-62,530 Reduced 9.2%
616,909 $60.1 Million
Q1 2022

May 09, 2022
BUY
$72.45 - $94.81 $16 Million - $20.9 Million
220,824 Added 48.15%
679,439 $63.7 Million
Q4 2021

Feb 11, 2022
BUY
$79.65 - $106.22 $1.17 Million - $1.56 Million
14,733 Added 3.32%
458,615 $39.1 Million
Q3 2021

Nov 10, 2021
SELL
$86.18 - $99.03 $471,921 - $542,288
-5,476 Reduced 1.22%
443,882 $42.6 Million
Q2 2021

Aug 10, 2021
BUY
$89.43 - $102.27 $749,065 - $856,613
8,376 Added 1.9%
449,358 $43.7 Million
Q1 2021

May 11, 2021
BUY
$87.57 - $119.4 $4.7 Million - $6.41 Million
53,699 Added 13.87%
440,982 $42.9 Million
Q4 2020

Feb 05, 2021
SELL
$86.91 - $108.33 $158,176 - $197,160
-1,820 Reduced 0.47%
387,283 $37.1 Million
Q3 2020

Nov 10, 2020
BUY
$96.16 - $135.15 $1.17 Million - $1.64 Million
12,137 Added 3.22%
389,103 $37.4 Million
Q2 2020

Aug 06, 2020
BUY
$85.09 - $130.36 $279,265 - $427,841
3,282 Added 0.88%
376,966 $46 Million
Q1 2020

May 11, 2020
BUY
$75.11 - $113.76 $6.34 Million - $9.6 Million
84,421 Added 29.18%
373,684 $32.3 Million
Q4 2019

Feb 10, 2020
SELL
$86.8 - $118.57 $691,362 - $944,410
-7,965 Reduced 2.68%
289,263 $31.1 Million
Q3 2019

Nov 05, 2019
BUY
$83.82 - $101.5 $5.17 Million - $6.26 Million
61,645 Added 26.17%
297,228 $26.8 Million
Q2 2019

Aug 06, 2019
SELL
$72.24 - $91.27 $231,167 - $292,064
-3,200 Reduced 1.34%
235,583 $19.9 Million
Q1 2019

May 14, 2019
BUY
$69.31 - $91.53 $427,088 - $564,007
6,162 Added 2.65%
238,783 $21 Million
Q4 2018

Feb 07, 2019
BUY
$68.32 - $124.36 $15.9 Million - $28.9 Million
232,621 New
232,621 $16.6 Million
Q3 2018

Nov 06, 2018
SELL
$98.88 - $125.85 $8.12 Million - $10.3 Million
-82,146 Closed
0 $0
Q2 2018

Aug 07, 2018
SELL
$75.3 - $105.99 $26,355 - $37,096
-350 Reduced 0.42%
82,146 $8.07 Million
Q1 2018

May 08, 2018
SELL
$75.88 - $92.43 $685,424 - $834,920
-9,033 Reduced 9.87%
82,496 $6.84 Million
Q4 2017

Jan 19, 2018
BUY
$58.53 - $77.59 $572,716 - $759,218
9,785 Added 11.97%
91,529 $7.1 Million
Q3 2017

Oct 11, 2017
BUY
$47.97 - $61.28 $3.92 Million - $5.01 Million
81,744
81,744 $5.01 Million

Others Institutions Holding NBIX

# of Institutions
724
Shares Held
102M
Call Options Held
230K
Put Options Held
477K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.9B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Gw&K Investment Management, LLC Portfolio

Follow Gw&K Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gw&K Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gw&K Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email